Testosterone-lowering therapy for prostate cancer may increase Alzheimer's risk

Men taking androgen deprivation therapy (ADT) for prostate cancer were almost twice as likely to be diagnosed with Alzheimer’s disease in the years that followed than those who didn’t undergo the therapy, an analysis of medical records from two large hospital systems has shown.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1SLqOhk